-
1 Comment
Chemed Corporation is currently in a long term downtrend where the price is trading 2.4% below its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.7.
Chemed Corporation's total revenue rose by 2.1% to $533M since the same quarter in the previous year.
Its net income has increased by 73.5% to $114M since the same quarter in the previous year.
Finally, its free cash flow grew by 40.5% to $71M since the same quarter in the previous year.
Based on the above factors, Chemed Corporation gets an overall score of 4/5.
Sector | Healthcare |
---|---|
Exchange | NYSE |
CurrencyCode | USD |
ISIN | US16359R1032 |
Industry | Medical Care Facilities |
Market Cap | 9B |
---|---|
PE Ratio | 29.12 |
Target Price | 675 |
Dividend Yield | 0.4% |
Beta | 0.49 |
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025